RxClub Awards 2008: Powerful & Simple
Top Rx Club Award winners exhibit qualities that ironically juxtapose industry's paradigm (pdf)
No Ordinary Joe
It's been a year since consumer marketing master Joe Jimenez took over the top spot at Novartis Pharma. How's he faring?
The Mess in MS
A five-year forecast of the multiple-sclerosis market following the disruptions of Tysabri
Resolving Conflicting Interests
As Congress moves to curb industry influence, support for med ed is waning
Size Doesn't Matter
Evaluating experience: It's what you know, not how long you know it
Pharm Exec Q&A: Tommy Thompson
The former health secretary offers a reality check on healthcare reform-and what to expect from the pols in '09
Over There
Is FDA's MO in foreign inspections too broken to fix?
Making Sense of Sales
Don't throw out sales force effectiveness with the sales force-some sure-fire strategies
Tech Toys
Here are the hottest gadgets and gizmos to make a dent in drug noncompliance
Gilding Lilly
Some say it's just another pharma facing its patent cliff. But others say this company's got it worse. With new CEO John Lechleiter in charge, can Lilly find its way back from the edge?
